Balance Needed Between IP Rights and Research Needs
Print This
November 17 -- Intellectual property restrictions rarely impose burdens on genomic and proteomic research, but there are reasons to be apprehensive about their future impact on advances in this field, says a new report from the National Research Council. Policy-makers should take steps to prevent the increasingly complex web of intellectual property protections from getting in the way of potential biomedical breakthroughs.
